BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011;22:3-17. [PMID: 21062128 DOI: 10.1089/hum.2010.211] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Nowak-stępniowska A, Osuchowska PN, Fiedorowicz H, Trafny EA, Gan Y. Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine. Stem Cells International 2022;2022:1-24. [DOI: 10.1155/2022/8775591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Nagelkerke A, Ojansivu M, van der Koog L, Whittaker TE, Cunnane EM, Silva AM, Dekker N, Stevens MM. Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities. Adv Drug Deliv Rev 2021;175:113775. [PMID: 33872693 DOI: 10.1016/j.addr.2021.04.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
3 Beliën H, Evens L, Hendrikx M, Bito V, Bronckaers A. Combining stem cells in myocardial infarction: The road to superior repair? Med Res Rev 2021. [PMID: 34114238 DOI: 10.1002/med.21839] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Alijani-Ghazyani Z, Sabzevari R, Roushandeh AM, Jahanian-Najafabadi A, Amiri F, Roudkenar MH. Transplantation of Umbilical Cord-Derived Mesenchymal Stem Cells Overexpressing Lipocalin 2 Ameliorates Ischemia-Induced Injury and Reduces Apoptotic Death in a Rat Acute Myocardial Infarction Model. Stem Cell Rev Rep 2020;16:968-78. [PMID: 32656623 DOI: 10.1007/s12015-020-10007-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zarrintaj P, Khodadadi Yazdi M, Youssefi Azarfam M, Zare M, Ramsey JD, Seidi F, Reza Saeb M, Ramakrishna S, Mozafari M. Injectable Cell-Laden Hydrogels for Tissue Engineering: Recent Advances and Future Opportunities. Tissue Eng Part A 2021;27:821-43. [PMID: 33779319 DOI: 10.1089/ten.TEA.2020.0341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xu M, Song J. Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era. Front Pharmacol 2021;12:623674. [PMID: 33935716 DOI: 10.3389/fphar.2021.623674] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Rodas G, Soler-Rich R, Rius-Tarruella J, Alomar X, Balius R, Orozco L, Masci L, Maffulli N. Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study. Am J Sports Med 2021;49:1492-504. [PMID: 33783227 DOI: 10.1177/0363546521998725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
8 Xu Y, Zhang T, Chen Y, Shi Q, Li M, Qin T, Hu J, Lu H, Liu J, Chen C. Isolation and Characterization of Multipotent Canine Urine-Derived Stem Cells. Stem Cells Int 2020;2020:8894449. [PMID: 33061993 DOI: 10.1155/2020/8894449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Whittaker TE, Nagelkerke A, Nele V, Kauscher U, Stevens MM. Experimental artefacts can lead to misattribution of bioactivity from soluble mesenchymal stem cell paracrine factors to extracellular vesicles. J Extracell Vesicles 2020;9:1807674. [PMID: 32944192 DOI: 10.1080/20013078.2020.1807674] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 10.5] [Reference Citation Analysis]
10 Goldberg AJ, Zaidi R, Brooking D, Kim L, Korda M, Masci L, Green R, O'Donnell P, Smith R. Autologous Stem Cells in Achilles Tendinopathy (ASCAT): protocol for a phase IIA, single-centre, proof-of-concept study. BMJ Open 2018;8:e021600. [PMID: 29764889 DOI: 10.1136/bmjopen-2018-021600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Ichihara Y, Kaneko M, Yamahara K, Koulouroudias M, Sato N, Uppal R, Yamazaki K, Saito S, Suzuki K. Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure. Biomaterials 2018;154:12-23. [PMID: 29117575 DOI: 10.1016/j.biomaterials.2017.10.050] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
12 Qayyum AA, Kaur KP, Mathiasen AB, Haack-Sørensen M, Ekblond A, Kastrup J. Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment. Scand J Clin Lab Invest 2017;77:541-8. [PMID: 28737959 DOI: 10.1080/00365513.2017.1354258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Yoon J, Lee TI, Bhang SH, Shin J, Myoung J, Kim B. Stretchable Piezoelectric Substrate Providing Pulsatile Mechanoelectric Cues for Cardiomyogenic Differentiation of Mesenchymal Stem Cells. ACS Appl Mater Interfaces 2017;9:22101-11. [DOI: 10.1021/acsami.7b03050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
14 Desrochers LM, Antonyak MA, Cerione RA. Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology. Dev Cell 2016;37:301-9. [PMID: 27219060 DOI: 10.1016/j.devcel.2016.04.019] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 21.8] [Reference Citation Analysis]
15 Li F, Guo X, Chen SY. Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis. Front Cardiovasc Med 2017;4:32. [PMID: 28589127 DOI: 10.3389/fcvm.2017.00032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
16 Zhou L, Lin Q, Wang P, Yao L, Leong K, Tan Z, Huang Z. Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia. Cell Death Dis 2017;8:e2774. [PMID: 28492549 DOI: 10.1038/cddis.2017.184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
17 Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 2016;96:1127-68. [PMID: 27335447 DOI: 10.1152/physrev.00019.2015] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 32.2] [Reference Citation Analysis]
18 Seo H, Lee S, Lee CY, Kim R, Kim P, Oh S, Lee H, Lee MY, Kim J, Kim LK, Hwang K, Chang W. Exogenous miRNA-146a Enhances the Therapeutic Efficacy of Human Mesenchymal Stem Cells by Increasing Vascular Endothelial Growth Factor Secretion in the Ischemia/Reperfusion-Injured Heart. J Vasc Res 2017;54:100-8. [DOI: 10.1159/000461596] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
19 Lee JH, Lee T, Choi JW. Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells. Nanomaterials (Basel) 2016;6:E224. [PMID: 28335352 DOI: 10.3390/nano6120224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
20 Dzobo K, Turnley T, Wishart A, Rowe A, Kallmeyer K, van Vollenstee FA, Thomford NE, Dandara C, Chopera D, Pepper MS, Parker MI. Fibroblast-Derived Extracellular Matrix Induces Chondrogenic Differentiation in Human Adipose-Derived Mesenchymal Stromal/Stem Cells in Vitro. Int J Mol Sci 2016;17:E1259. [PMID: 27527147 DOI: 10.3390/ijms17081259] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
21 Pumberger M, Qazi TH, Ehrentraut MC, Textor M, Kueper J, Stoltenburg-didinger G, Winkler T, von Roth P, Reinke S, Borselli C, Perka C, Mooney DJ, Duda GN, Geißler S. Synthetic niche to modulate regenerative potential of MSCs and enhance skeletal muscle regeneration. Biomaterials 2016;99:95-108. [DOI: 10.1016/j.biomaterials.2016.05.009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
22 Dall C, Khan M, Chen CA, Angelos MG. Oxygen cycling to improve survival of stem cells for myocardial repair: A review. Life Sci 2016;153:124-31. [PMID: 27091653 DOI: 10.1016/j.lfs.2016.04.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
23 Zhao L, Liu X, Zhang Y, Liang X, Ding Y, Xu Y, Fang Z, Zhang F. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. Exp Cell Res 2016;344:30-9. [PMID: 27025401 DOI: 10.1016/j.yexcr.2016.03.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
24 Höfig I, Ingawale Y, Atkinson MJ, Hertlein H, Nelson PJ, Rosemann M. p53-Dependent Senescence in Mesenchymal Stem Cells under Chronic Normoxia Is Potentiated by Low-Dose γ-Irradiation. Stem Cells Int 2016;2016:6429853. [PMID: 26788069 DOI: 10.1155/2016/6429853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
25 Ahmadian E, Jafari S, Yari Khosroushahi A. Role of angiotensin II in stem cell therapy of cardiac disease. J Renin Angiotensin Aldosterone Syst 2015;16:702-11. [PMID: 26670032 DOI: 10.1177/1470320315621225] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
26 Roubeix C, Godefroy D, Mias C, Sapienza A, Riancho L, Degardin J, Fradot V, Ivkovic I, Picaud S, Sennlaub F, Denoyer A, Rostene W, Sahel JA, Parsadaniantz SM, Brignole-Baudouin F, Baudouin C. Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma. Stem Cell Res Ther. 2015;6:177. [PMID: 26377305 DOI: 10.1186/s13287-015-0168-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
27 Zhang Y, Chiu S, Liang X, Gao F, Zhang Z, Liao S, Liang Y, Chai YH, Low DJ, Tse HF, Tergaonkar V, Lian Q. Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction. Cell Death Discov 2015;1:15007. [PMID: 27551443 DOI: 10.1038/cddiscovery.2015.7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 9.1] [Reference Citation Analysis]
28 Xie N, Li Z, Adesanya TM, Guo W, Liu Y, Fu M, Kilic A, Tan T, Zhu H, Xie X. Transplantation of placenta-derived mesenchymal stem cells enhances angiogenesis after ischemic limb injury in mice. J Cell Mol Med 2016;20:29-37. [PMID: 26282458 DOI: 10.1111/jcmm.12489] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
29 Neofytou E, Deuse T, Beygui RE, Schrepfer S. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties. Transplantation 2015;99:1113-8. [PMID: 26035274 DOI: 10.1097/TP.0000000000000734] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
30 Hayashi E, Hosoda T. Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells. Heart Fail Rev 2014;19:789-97. [PMID: 24743881 DOI: 10.1007/s10741-014-9430-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
31 Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116:1413-1430. [PMID: 25858066 DOI: 10.1161/circresaha.116.303614] [Cited by in Crossref: 256] [Cited by in F6Publishing: 265] [Article Influence: 36.6] [Reference Citation Analysis]
32 Hayashi Y, Murakami M, Kawamura R, Ishizaka R, Fukuta O, Nakashima M. CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells. Stem Cell Res Ther 2015;6:111. [PMID: 26021377 DOI: 10.1186/s13287-015-0088-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
33 Rusu MC, Vrapciu AD, Hostiuc S, Hariga CS. Brown adipocytes, cardiac protection and a common adipo- and myogenic stem precursor in aged human hearts. Med Hypotheses 2015;85:212-4. [PMID: 25956736 DOI: 10.1016/j.mehy.2015.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Yu J, Wu YK, Gu Y, Fang Q, Sievers R, Ding CH, Olgin JE, Lee RJ. Immuno-modification of enhancing stem cells targeting for myocardial repair. J Cell Mol Med 2015;19:1483-91. [PMID: 25904069 DOI: 10.1111/jcmm.12439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
35 Zhao YD, Huang X, Yi F, Dai Z, Qian Z, Tiruppathi C, Tran K, Zhao YY. Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury. Stem Cells 2014;32:1855-64. [PMID: 24578354 DOI: 10.1002/stem.1690] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
36 Johnstone SA, Liley M, Dalby MJ, Barnett SC. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater 2015;13:266-76. [PMID: 25463488 DOI: 10.1016/j.actbio.2014.11.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
37 Gazdhar A, Grad I, Tamò L, Gugger M, Feki A, Geiser T. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther 2014;5:123. [PMID: 25384638 DOI: 10.1186/scrt513] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
38 King YA, Chiu YJ, Chen HP, Kuo DH, Lu CC, Yang JS. Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol 2016;31:314-28. [PMID: 25258189 DOI: 10.1002/tox.22046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
39 Boomsma RA, Geenen DL. Evidence for Transfer of Membranes from Mesenchymal Stem Cells to HL-1 Cardiac Cells. Stem Cells Int 2014;2014:653734. [PMID: 25295065 DOI: 10.1155/2014/653734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Lin CH, Lilly B. Endothelial cells direct mesenchymal stem cells toward a smooth muscle cell fate. Stem Cells Dev 2014;23:2581-90. [PMID: 24914692 DOI: 10.1089/scd.2014.0163] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
41 Silva DN, de Freitas Souza BS, Azevedo CM, Vasconcelos JF, Carvalho RH, Soares MB, Dos Santos RR. Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy. Stem Cell Res Ther. 2014;5:81. [PMID: 24984860 DOI: 10.1186/scrt470] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wang X, Xi WC, Wang F. The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction. Biotechnol Lett 2014;36:2163-8. [PMID: 24975729 DOI: 10.1007/s10529-014-1589-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
43 Schade A, Müller P, Delyagina E, Voronina N, Skorska A, Lux C, Steinhoff G, David R. Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs. Stem Cells Int 2014;2014:197154. [PMID: 24799915 DOI: 10.1155/2014/197154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
44 Nakamura R, Nakamura F, Fukunaga S. Changes in the composition of the extracellular matrix accumulated by mesenchymal stem cells during in vitro expansion. Anim Sci J 2014;85:706-13. [PMID: 24612364 DOI: 10.1111/asj.12187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Shi B, Long X, Zhao R, Liu Z, Wang D, Xu G. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model. Exp Biol Med (Maywood) 2014;239:356-65. [PMID: 24477823 DOI: 10.1177/1535370213517619] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
46 Liehn EA, Radu E, Schuh A. Chemokine contribution in stem cell engraftment into the infarcted myocardium. Curr Stem Cell Res Ther 2013;8:278-83. [PMID: 23547962 DOI: 10.2174/1574888x11308040003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
47 He J, Teng X, Yu Y, Huang H, Ye W, Ding Y, Shen Z. Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model. Differentiation 2013;86:57-64. [PMID: 23974360 DOI: 10.1016/j.diff.2013.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
48 Chen WC, Park TS, Murray IR, Zimmerlin L, Lazzari L, Huard J, Péault B. Cellular kinetics of perivascular MSC precursors. Stem Cells Int 2013;2013:983059. [PMID: 24023546 DOI: 10.1155/2013/983059] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
49 Melly LF, Marsano A, Frobert A, Boccardo S, Helmrich U, Heberer M, Eckstein FS, Carrel TP, Giraud MN, Tevaearai HT, Banfi A. Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels. Hum Gene Ther Methods 2012;23:346-56. [PMID: 23075102 DOI: 10.1089/hgtb.2012.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
50 Jiang Z, Hu X, Yu H, Xu Y, Wang L, Chen H, Chen H, Wu R, Zhang Z, Xiang C, Webster KA, Wang JA. Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms. J Cell Mol Med. 2013;17:1247-1260. [PMID: 23837896 DOI: 10.1111/jcmm.12100] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
51 Toupet K, Maumus M, Peyrafitte J, Bourin P, van Lent PLEM, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D. Long-Term Detection of Human Adipose-Derived Mesenchymal Stem Cells After Intraarticular Injection in SCID Mice: Biodistribution and Long-Term Detection of Human AD-MSCs in SCID Mice. Arthritis & Rheumatism 2013;65:1786-94. [DOI: 10.1002/art.37960] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
52 Hayashi E, Hosoda T. Therapeutic application of cardiac stem cells and other cell types. Biomed Res Int. 2013;2013:736815. [PMID: 23878816 DOI: 10.1155/2013/736815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
53 Zhu XY, Urbieta-Caceres V, Krier JD, Textor SC, Lerman A, Lerman LO. Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells. 2013;31:117-125. [PMID: 23097349 DOI: 10.1002/stem.1263] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 11.6] [Reference Citation Analysis]
54 Roy R, Brodarac A, Kukucka M, Kurtz A, Becher PM, Jülke K, Choi YH, Pinzur L, Chajut A, Tschöpe C. Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model. J Surg Res. 2013;185:70-83. [PMID: 23830369 DOI: 10.1016/j.jss.2013.05.084] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
55 Schade A, Delyagina E, Scharfenberg D, Skorska A, Lux C, David R, Steinhoff G. Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles. Int J Mol Sci 2013;14:10710-26. [PMID: 23702843 DOI: 10.3390/ijms140610710] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
56 Houtgraaf JH, de Jong R, Kazemi K, de Groot D, van der Spoel TI, Arslan F, Hoefer I, Pasterkamp G, Itescu S, Zijlstra F, Geleijnse ML, Serruys PW, Duckers HJ. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function. Circ Res. 2013;113:153-166. [PMID: 23658436 DOI: 10.1161/circresaha.112.300730] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 8.2] [Reference Citation Analysis]
57 Gao LR, Pei XT, Ding QA, Chen Y, Zhang NK, Chen HY, Wang ZG, Wang YF, Zhu ZM, Li TC. A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction. Int J Cardiol. 2013;168:3191-3199. [PMID: 23651816 DOI: 10.1016/j.ijcard.2013.04.112] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
58 Catacchio I, Berardi S, Reale A, De Luisi A, Racanelli V, Vacca A, Ria R. Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation. Stem Cells Int 2013;2013:589139. [PMID: 23606860 DOI: 10.1155/2013/589139] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
59 Takashima S, Tempel D, Duckers HJ. Current outlook of cardiac stem cell therapy towards a clinical application. Heart 2013;99:1772-84. [PMID: 23525708 DOI: 10.1136/heartjnl-2012-303308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
60 Lin X, Li HY, Chen LF, Liu BJ, Yao Y, Zhu WL. Enhanced differentiation potential of human amniotic mesenchymal stromal cells by using three-dimensional culturing. Cell Tissue Res 2013;352:523-35. [PMID: 23515591 DOI: 10.1007/s00441-013-1576-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Li Y, Zhao Y, Cheng Z, Zhan J, Sun X, Qian H, Zhu W, Xu W. Mesenchymal stem cell-like cells from children foreskin inhibit the growth of SGC-7901 gastric cancer cells. Exp Mol Pathol. 2013;94:430-437. [PMID: 23421973 DOI: 10.1016/j.yexmp.2013.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
62 Narita T, Shintani Y, Ikebe C, Kaneko M, Campbell NG, Coppen SR, Uppal R, Sawa Y, Yashiro K, Suzuki K. The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure. Mol Ther 2013;21:860-7. [PMID: 23358187 DOI: 10.1038/mt.2013.9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
63 Ramkisoensing AA, Pijnappels DA, Swildens J, Goumans MJ, Fibbe WE, Schalij MJ, de Vries AA, Atsma DE. Gap junctional coupling with cardiomyocytes is necessary but not sufficient for cardiomyogenic differentiation of cocultured human mesenchymal stem cells. Stem Cells 2012;30:1236-45. [PMID: 22438316 DOI: 10.1002/stem.1086] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
64 Melly L, Boccardo S, Eckstein F, Banfi A, Marsano A. Cell and gene therapy approaches for cardiac vascularization. Cells 2012;1:961-75. [PMID: 24710537 DOI: 10.3390/cells1040961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
65 Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Cell. 2012;10:740-749. [PMID: 22704514 DOI: 10.1016/j.stem.2012.05.010] [Cited by in Crossref: 172] [Cited by in F6Publishing: 149] [Article Influence: 17.2] [Reference Citation Analysis]
66 Drey F, Choi YH, Neef K, Ewert B, Tenbrock A, Treskes P, Bovenschulte H, Liakopoulos OJ, Brenkmann M, Stamm C, Wittwer T, Wahlers T. Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI. Cell Transplant 2013;22:1971-80. [PMID: 23050950 DOI: 10.3727/096368912X657747] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
67 Faça VM. Human mesenchymal stromal cell proteomics: contribution for identification of new markers and targets for medicine intervention. Expert Rev Proteomics 2012;9:217-30. [PMID: 22462791 DOI: 10.1586/epr.12.9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
68 Donndorf P, Strauer BE, Steinhoff G. Update on cardiac stem cell therapy in heart failure. Curr Opin Cardiol 2012;27:154-60. [PMID: 22249215 DOI: 10.1097/HCO.0b013e32834fe969] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
69 Neef K, Choi Y, Weichel A, Rahmanian PB, Liakopoulos OJ, Stamm C, Choi CY, Jacobshagen C, Wittwer T, Wahlers T. The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness. Cytotherapy 2012;14:670-8. [DOI: 10.3109/14653249.2012.663483] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
70 Zhang Z, Alexanian AR. The neural plasticity of early-passage human bone marrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agents: Neural plasticity of early passage BM-hMSCs. J Tissue Eng Regen Med 2014;8:407-13. [DOI: 10.1002/term.1535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
71 Bieback K, Wuchter P, Besser D, Franke W, Becker M, Ott M, Pacher M, Ma N, Stamm C, Klüter H, Müller A, Ho AD; for the START-MSC consortium. Mesenchymal stromal cells (MSCs): science and f(r)iction. J Mol Med 2012;90:773-82. [DOI: 10.1007/s00109-012-0915-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
72 Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? vs21:2724-2752. [PMID: 22468918 DOI: 10.1089/scd.2011.0722] [Cited by in Crossref: 463] [Cited by in F6Publishing: 490] [Article Influence: 46.3] [Reference Citation Analysis]
73 Cho SW, Sun HJ, Yang J, Jung JY, Choi HJ, An JH, Kim SW, Kim SY, Park K, Shin CS. Human Adipose Tissue-Derived Stromal Cell Therapy Prevents Bone Loss in Ovariectomized Nude Mouse. Tissue Engineering Part A 2012;18:1067-78. [DOI: 10.1089/ten.tea.2011.0355] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
74 Prasongchean W, Ferretti P. Autologous stem cells for personalised medicine. N Biotechnol 2012;29:641-50. [PMID: 22561284 DOI: 10.1016/j.nbt.2012.04.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
75 Houtgraaf JH, de Jong R, Monkhorst K, Tempel D, van de Kamp E, den Dekker WK, Kazemi K, Hoefer I, Pasterkamp G, Lewis AL, Stratford PW, Wallrapp C, Zijlstra F, Duckers HJ. Feasibility of intracoronary GLP-1 eluting CellBead™ infusion in acute myocardial infarction. Cell Transplant 2013;22:535-43. [PMID: 22507673 DOI: 10.3727/096368912X638973] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
76 Sharma AK. An examination of regenerative medicine-based strategies for the urinary bladder. Regen Med 2011;6:583-98. [PMID: 21916594 DOI: 10.2217/rme.11.47] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
77 Tang D, Zhu H, Wu J, Chen H, Zhang Y, Zhao X, Chen X, Du W, Wang D, Lin X. Silencing myostatin gene by RNAi in sheep embryos. J Biotechnol. 2012;158:69-74. [PMID: 22285957 DOI: 10.1016/j.ypmed.2012.01.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
78 Liehn EA, Postea O, Curaj A, Marx N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol 2011;58:2357-62. [PMID: 22115639 DOI: 10.1016/j.jacc.2011.08.034] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 9.0] [Reference Citation Analysis]
79 Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol 2012;45:87-98. [PMID: 22161544 DOI: 10.1007/s12035-011-8219-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
80 Mansilla E, Aquino VD, Roque G, Tau JM, Maceira A. Time and regeneration in burns treatment: heading into the first worldwide clinical trial with cadaveric mesenchymal stem cells. Burns 2012;38:450-2. [PMID: 22040934 DOI: 10.1016/j.burns.2011.09.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
81 Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang BC, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 2011;9:181. [PMID: 22017805 DOI: 10.1186/1479-5876-9-181] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
82 Dai W, Kloner RA. Bone Marrow-Derived Cell Transplantation Therapy for Myocardial Infarction: Lessons Learned and Future Questions: Bone Marrow-Derived Cells and Myocardial Infarction. American Journal of Transplantation 2011;11:2297-301. [DOI: 10.1111/j.1600-6143.2011.03750.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
83 Rapti K, Chaanine AH, Hajjar RJ. Targeted gene therapy for the treatment of heart failure. Can J Cardiol 2011;27:265-83. [PMID: 21601767 DOI: 10.1016/j.cjca.2011.02.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
84 Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat J, Warnock GL. Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 2011;305:8-20. [PMID: 21396770 DOI: 10.1016/j.canlet.2011.02.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]